Ohm, thanks so much for the reply and explanation. I couldn't figure it out while all the other "usual suspects" biomarkers were there, everywhere. And the project being tied to the Harvard-MIT medical research and training establishment really blew me away.

Still, lack of any mention of CCL5 and CCR5 for the reasons you've stated almost seems like a pass for them on a technicality. I do hope that crowd does give our favorite ligand and receptor their fair due sooner rather than later. It's their loss if they don't.

We know what kind of immune response you might get without them!